Jiang Tingliang. Effect of the Extract of Spirobolus bungii on the Transplanted Tumors in Mice[J]. Journal of Traditional Chinese Medicine1980, (6): 59-63.
Jiang Tingliang. Effect of the Extract of Spirobolus bungii on the Transplanted Tumors in Mice[J]. Journal of Traditional Chinese Medicine1980, (6): 59-63.DOI: 10.13288/j.11-2166/r.1980.06.030.
Effect of the Extract of Spirobolus bungii on the Transplanted Tumors in Mice
摘要
<正> 河南省南阳地区民间流传用燕山蛩治疗食管癌。《本草纲目》记载它“有大毒”
可“烧黑
傅恶疮”。我们在采风的基础上对它进行了动物实验
在实验中发现
它的提取物对小鼠某些移植性肿瘤生长有一定抑制作用
且毒性不大。现将结果报道如下。
Abstract
The antitumor effect of Spirobolus bun-gii extracts was studied in mice with soliduterocervical carcinoma(U
14
)
sarcoma
37
(S
37
)
Lewis lung carcinoma(Lewis)andascites uterocervical carcinoma(U
14
A)
sar-coma
180
(S
180
A)
Ehrlich tumor(ECA).The agents tested included water
ethanol
ether and ethanol-ether extracts.All extractswere administered in solid tumor-bearingmice intraperitoneally for 12—14 days andascites tumor-bearing mice for 4—8 days.The optimal daily dose established for these4 extracts was 0.3
1.3
0.15—0.3 and 0.05—0.2 gm/kg respectively.The tumor growthinhibiting effect was determined for theseextracts in animal with U
14
Lewis and U
14
A
S
180
A
ECA;it ranged from 28.2 to 59.8%in solid tumor and from 72.8 to more than95% in ascites
but water extract showed noinhibiting effect on growth.Treating theanimal with U
14
by ethanol-ether(0.2gm/kgdaily for one
six and nine days)
the ratioof survival time as compared with the con-trol group was 155
163 and 207% respecti-vely.The toxic tests of ethanol-ether ex-tract showed that its safety coefficient wasmore than 10
and there was no obvious har-mful effect on the heart
lung
spleen
kid-ney except a slight hepatatrophic effect inmice with 0.1—0.4gm/kg/day dose for 26days.
The Philosophy and Practical Pathway of "Dao (道)-Shen (神)-Formula" in Traditional Chinese Medicine
Clinical Efficacy and Economic Evaluation of 1293 Non-Severe Adult Patients with Community-Acquired Pneumonia Treated by the Jiangsu Traditional Chinese Medicine Diagnosis and Treatment Protocol for Dominant Diseases:A Multicenter,Retrospective Real-World Cohort Study
Differentiation and Treatment of Small Cell Lung Cancer from the Perspective of "Internal Wind in Hidden Circulation"
Efficacy and Economic Evaluation of Weishi Qingjin Formula (苇石清金方)in the Treatment of Adult Community-Acquired Pneumonia with Phlegm-Heat Obstructing the Lung Syndrome:A Multicenter Retrospective Real-World Cohort Study
Challenges and Recommendations for Implementing Key Technologies in Decentralized Clinical Trials of Traditional Chinese Medicine